Motley Fool Australia

Creso Pharma Ltd (ASX: CPH) Share Price and News

Price
Movement
52 Week Range
-
1 Year Return
(20 mins delayed)

() Chart and Price Data

.

Share Price
Previous Close
Volume
Day Change
Open
Monthly Average Volume
52 Week Range -
Days Range -
Turnover

Fundamental Company Figures

Data provided by Morningstar.
Market Cap $195.47 million
P/E Ratio N/A
Dividend Yield N/A
Shares Outstanding 949.39 million
Earnings per share -0.094
Dividend per share N/A
Year To Date Return 16.67%
Earnings Yield N/A
Franking N/A

Creso Pharma Ltd (ASX: CPH) Latest News

Happy investor punches air in front of laptop

Here’s why the Creso Pharma (ASX:CPH) share price is storming 11% higher

More »

Why the Creso Pharma (ASX:CPH) share price is tumbling 5% lower

More »

red arrow pointing down, falling share price

Why Cann, Creso, LiveTiles, & New Corp shares are tumbling lower today

More »

A man climbing stairs that go up and down in a chart style, indicating a moving share price

What’s happening with the Creso Pharma (ASX:CPH) share price today?

More »

shares valuation higher upgrade, growth shares

Why Blackmores, Creso Pharma, Pilbara Minerals, & Zip shares are pushing higher

More »

cannabis leaves on a rising line graph representing growth of ASX cannabis shares

Here’s why the Creso Pharma (ASX:CPH) share price is rocketing 18% higher

More »

share price higher

Why Bingo, Creso Pharma, Domino’s, & Tyro shares are zooming higher today

More »

cannabis leaves on a rising line graph representing growth of ASX cannabis shares

Why the Creso Pharma (ASX:CPH) share price is smoking the market today

More »

Recent Stock Announcements

Price Sensitive Only$An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Show All
Date Heading $An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security. Time Pages File Size
 

About Creso Pharma Ltd (ASX: CPH)

Creso Pharma Ltd is engaged in developing, registering, and commercialization of pharmaceutical-grade cannabis and hemp-based nutraceutical products and treatments for human and animal health. Its product portfolio includes Creso Animal Health products, Nutraceutical products, Topical products, Therapeutics products, and Lifestyle products. The company has operations in Switzerland, Canada, Colombia, Israel and Australia. The company derives prime revenue from the Europe andMiddle East regions.

Share Price History

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
03 Mar 2021 $0.21 $0.00 0.00% 5,077,918 $0.21 $0.21 $0.20
02 Mar 2021 $0.21 $-0.01 -4.76% 7,578,196 $0.21 $0.22 $0.20
01 Mar 2021 $0.21 $0.00 0.00% 27,063,400 $0.21 $0.22 $0.20
26 Feb 2021 $0.21 $-0.01 -4.55% 4,731,225 $0.21 $0.22 $0.21
25 Feb 2021 $0.22 $0.00 0.00% 6,945,703 $0.22 $0.23 $0.21
24 Feb 2021 $0.22 $-0.01 -4.35% 6,135,869 $0.23 $0.23 $0.22
23 Feb 2021 $0.23 $-0.01 -4.17% 6,404,891 $0.24 $0.25 $0.23
22 Feb 2021 $0.24 $0.01 4.26% 10,303,337 $0.24 $0.25 $0.24
19 Feb 2021 $0.24 $0.00 0.00% 9,640,455 $0.24 $0.24 $0.23
18 Feb 2021 $0.24 $0.00 0.00% 10,279,939 $0.23 $0.24 $0.23
17 Feb 2021 $0.23 $0.01 4.44% 11,089,096 $0.23 $0.24 $0.23
16 Feb 2021 $0.23 $-0.01 -4.35% 7,001,594 $0.23 $0.24 $0.23
15 Feb 2021 $0.23 $0.01 4.44% 28,843,597 $0.24 $0.25 $0.23
12 Feb 2021 $0.23 $-0.01 -4.35% 18,182,043 $0.22 $0.24 $0.22
11 Feb 2021 $0.23 $-0.04 -15.09% 39,514,080 $0.26 $0.27 $0.23
10 Feb 2021 $0.27 $0.05 23.26% 60,430,139 $0.23 $0.27 $0.22
09 Feb 2021 $0.22 $0.01 4.88% 6,844,488 $0.21 $0.22 $0.21
08 Feb 2021 $0.21 $-0.01 -4.76% 12,510,948 $0.21 $0.21 $0.20
05 Feb 2021 $0.21 $0.00 0.00% 6,760,047 $0.22 $0.22 $0.21
04 Feb 2021 $0.21 $0.00 0.00% 9,245,781 $0.22 $0.22 $0.21
03 Feb 2021 $0.21 $0.00 0.00% 8,026,150 $0.22 $0.23 $0.21
02 Feb 2021 $0.21 $-0.01 -4.65% 11,665,792 $0.22 $0.24 $0.21
Show more

Director Transactions

Data provided by Morningstar.
Date Director Type Amount Value Notes
22 Jan 2021 Adam Blumenthal Issued 87 $18,879,575
23 Dec 2020 Adam Blumenthal Issued 137 $4,000,000
12 Oct 2020 Miriam Wernli Issued 833 $49,999
12 Oct 2020 Adam Blumenthal Issued 833 $49,999
02 Jun 2020 Adam Blumenthal Issued 12 $720,000


Directors & Management

Data provided by Morningstar.
Name Title StartDate Profile
Mr Adam Blumenthal Non-Executive Director,Non-Executive Chairman Nov 2015
Dr James Anthony Ellingford Executive Director Nov 2015
Mr Boaz Wachtel Non-Executive Director Nov 2015
Dr Miriam Halperin Wernli Executive Director,Technology, Innovation & Distribution head Oct 2016
Mr Winton William Willesee Joint Company Secretary Oct 2018
Ms Erlyn Dale Joint Company Secretary Oct 2018
Christopher Grundy Chief Financial Officer
Winton William Willesee Joint Company Secretary
Erlyn Dale Joint Company Secretary
Show more

Top Share Holders

Data provided by Morningstar.
Name Shares Capital
Jamber Investments Pty Ltd<The Amber Schwarz Fam A/C> 22,140,303 10.99%
Miriam Halperin Wernli 12,500,000 6.21%
HSBC Custody Nominees (Australia) Limited 9,146,887 4.54%
CS Third Nominees Pty Limited <Hsbc Cust Nom Au Ltd 13 A/C> 8,847,971 4.39%
International Water Energy Savers Ltd 8,300,000 4.12%
Anglo Australasia Holdings Pty Ltd <Anglo Australasia A/C> 6,250,000 3.10%
J P Morgan Nominees Australia Pty Limited 4,275,787 2.12%
Suburban Holdings Pty Limited <Suburban Super Fund A/C> 3,786,095 1.88%
BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient Drp> 3,450,914 1.71%
Citicorp Nominees Pty Limited 2,941,119 1.46%
Atlantic Capital Holdings Pty <Atlantic Capital A/C> 1,958,387 0.97%
Pheakes Pty Ltd <Senate A/C> 1,577,875 0.78%
Dorson Commercial Corp 1,549,618 0.77%
Mr James Anthony Ellingford 1,450,000 0.72%
Blueknight Corporation Pty Ltd 1,333,334 0.66%
Mr Peppi Schiano Dicola 1,300,000 0.65%
Eighteen Speed Overdrive Pty Ltd <The Galaxy Supernova Sf A/C> 1,157,501 0.57%
Bb Enterprises Bvi 1,056,752 0.52%
S3 Consortium Pty Ltd 1,000,000 0.50%
Pedro Tosin 925,063 0.46%
Show more